Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
    • American Diagnosis
    • Where It Hurts
  • Investigations
    • Bill Of The Month
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Payback: Tracking Opioid Cash
    • Systemic Sickness
    • The Injured
    • The Only Hospital in Town
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured

Search Results

Filter Results

Reset filters
Date
Custom Date Range
Topic
Content Type

Showing 301-320 of 1,551 results for "medicare advantage"

Sort by
A photo of a sign bearing Ballad Health's logo outside of Johnston Memorial Hospital.

After Appalachian Hospitals Merged Into a Monopoly, Their ERs Slowed to a Crawl

By Brett Kelman and Samantha Liss March 25, 2024 KFF Health News Original

Ballad Health was granted the nation’s largest state-sanctioned hospital monopoly in 2018. Since then, its emergency rooms have become more than three times as slow.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

KFF Health News' 'What the Health?': Judging the Abortion Pill

March 16, 2023 Podcast

Any day now a conservative federal judge in Texas could upend the national abortion debate by requiring the FDA to rescind its approval of mifepristone, a drug approved in the U.S. more than 20 years ago that is now used in more than half of abortions nationwide. Meanwhile, a controversial study on masks gets a clarification, although it may be too late to change the public impression of what it found. Alice Miranda Ollstein of Politico, Jessie Hellmann of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

KFF Health News' 'What the Health?': A Health-Heavy State of the Union

February 9, 2023 Podcast

President Joe Biden’s 2023 State of the Union address leaned heavily on health care issues. Biden took a victory lap for recent accomplishments like capping prescription drug costs for seniors on Medicare. He also urged Congress to make permanent the boosted premium subsidies under the Affordable Care Act, and he sparred with Republicans on threats to cut Social Security and Medicare. Also this week, both sides in the abortion debate are bracing for a court decision out of Texas that could, at least temporarily, make the abortion pill mifepristone illegal nationwide. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Kate Baicker of the University of Chicago about a possible middle ground in the effort to get universal health insurance coverage.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

Clarity on Covid Count: Pandemic’s Toll on Seniors Extended Well Beyond Nursing Homes

By Judith Graham August 6, 2021 KFF Health News Original

The latest research shows that although deaths in nursing homes received enormous attention, far more older adults who perished from covid lived outside of institutions. People with dementia and other severe neurological conditions, chronic kidney disease and immune deficiencies were hit especially hard.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print
A photo of the Amgen logo sign outside of its headquarters, framed by foliage.

Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge

By Arthur Allen May 7, 2024 KFF Health News Original

The FDA told Amgen to test whether a quarter-dose of its lung cancer drug worked as well as the amount recommended on the product label. It did and with fewer side effects. But Amgen is sticking to the higher dose — which earns it an additional $180,000 a year per patient.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print
A stethoscope atop hundred-dollar bills on a flat surface.

Why Many Nonprofit (Wink, Wink) Hospitals Are Rolling in Money

By Elisabeth Rosenthal July 29, 2024 KFF Health News Original

Legal maneuvering, industry lobbying, and lax IRS oversight leave lots of room for “operating surpluses.”

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

Medicare Open Enrollment Is Complicated. Here’s How to Get Good Advice.

By Bernard J. Wolfson November 24, 2020 KFF Health News Original

It’s a complex program with many options — as well as confusing rules and nuances. Here’s how to get reliable guidance.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

Her Doctor’s Office Moved One Floor Up. Her Bill Was 10 Times Higher.

By Lauren Weber March 26, 2021 KFF Health News Original

Same building. Same procedure. Same doctor. But now you’re charged a hospital facility fee. For one Ohio Medicare patient, the copay for a shot that used to cost her about $30 went up to more than $300.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

Dentists Chip Away at Uninsured Problem by Offering Patients Membership Plans

By Phil Galewitz September 17, 2021 KFF Health News Original

The plans are designed for people who don’t get dental coverage through their jobs and can’t afford an individual plan. For about $300 to $400 a year, patients receive certain preventive services at no charge and other procedures at a discount.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

Readers and Tweeters Give Tips on Treating Diabetes and Long Covid

April 12, 2021 KFF Health News Original

Kaiser Health News gives readers a chance to comment on a recent batch of stories.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

Though Millions Are at Risk for Diabetes, Medicare Struggles to Expand Prevention Program

By Harris Meyer July 21, 2021 KFF Health News Original

Medicare has proposed revamping its payment rules to get more people into a diabetes prevention plan that helps them eat better, exercise more and maintain a healthier lifestyle. Out of an estimated 16 million Medicare beneficiaries whose excess weight and other risk factors make them eligible, only 3,600 have participated since 2018.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

Medicare Advantage Plans Too Often Deny Care, HHS Watchdog Reports

April 29, 2022 Morning Briefing

The inspector general’s office urged HHS officials to increase oversight of the private insurance plans.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print
A close-up of a pharmacist scanning a prescription.

When Copay Assistance Backfires on Patients

By Julie Appleby March 15, 2024 KFF Health News Original

Drugmakers offer copay assistance programs to patients, but insurers are tapping into those funds, not counting the amounts toward patient deductibles. That leads to unexpected charges. But the practice is under growing scrutiny.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

A Daily Pill to Treat Covid Could Be Just Months Away, Scientists Say

By JoNel Aleccia September 24, 2021 KFF Health News Original

At least three promising antiviral treatments for covid-19 are being tested in clinical trials, with results expected as soon as late fall or winter.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

Inflation To Impact Negotiations Between Health Providers, Insurers

June 29, 2022 Morning Briefing

Modern Healthcare warns negotiations between health providers and insurers may be “bloody” thanks to the impact of inflation, which rose for general goods more than health care in May. Separately, Medicare Advantage is chastised by government watchdogs for denying care and overcharging.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print
A photo of three boxes of Wegovy.

Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers

By Rachana Pradhan August 8, 2023 KFF Health News Original

Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

CMS Eyes 8% Hike In Payments To Medicare Advantage Providers Next Year

February 3, 2022 Morning Briefing

The proposed adjustment in 2023 payments would be to address the financial impacts of social determinants of health and health equity in Medicare Advantage plans.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

Apple, Bose and Others Pump Up the Volume on Hearing Aid Options, Filling Void Left by FDA

By Phil Galewitz August 26, 2021 KFF Health News Original

A 2017 law designed to help lower the cost of hearing aids mandated that federal officials set rules for a new class of devices consumers could buy without needing to see an audiologist. But those regulations are still on hold.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print

Pushback At Medicare Plan To Limit Hospital Medical Complication Reports

June 6, 2022 Morning Briefing

Consumer groups and employers, USA Today reports, are resisting a plan by Medicare to limit public reporting of certain often-preventable complications that happen during hospital stays. Separately, Medicare Advantage insurance firms are accused of data mining patient records to make false bills.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print
A photo of a medical billing statement.

Ouch. That ‘Free’ Annual Checkup Might Cost You. Here’s Why.

By Elisabeth Rosenthal January 26, 2024 KFF Health News Original

The designers of the Affordable Care Act might have assumed that they spelled out with sufficient clarity that millions of Americans would no longer have to pay for certain types of preventive care. But they didn’t reckon with America’s ever-creative medical billing juggernaut.

  • X
  • Facebook
  • LinkedIn
  • Email
  • Print
  • Previous
  • 14
  • 15
  • 16
  • 17
  • 18
  • Next

More From KFF Health News

A photo of an area in a pharmacy with filled prescriptions.

Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs

Journalists Unpack Drug Prices, Threats to Medicaid, and the Fluoridation of Water

A photo looking up at the Jacob K. Javits Federal Building at 26 Federal Plaza. It is a tall skyscraper in New York City.

In Bustling NYC Federal Building, HHS Offices Are Eerily Quiet

Even Where Abortion Is Still Legal, Many Brick-and-Mortar Clinics Are Closing

KFF

© 2025 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting Kaiser Health News (KHN), the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue